Clinical trial

MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer

NCT00374049

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-06-01

PhasePHASE1

Study timeline

Study start (unknown)2006-06-01Date precision: month

Registry last updated2016-07-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

MUC_1DRUG

Sponsors & collaborators

Olivera Finnlead sponsor

Oncovir, Inc.collaborator

Mapped research locations

PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00374049 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.